MG

Madhu Ganghadharan

Active Director Director DIN 03302027
DIN 03302027 First appointment Jan 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhu Ganghadharan

Data last updated:

Madhu Ganghadharan is a Director at Agastya Biopharm India Limited (since 2011). The company operates in Pharma.

DIN 03302027
Primary Designation Director
Industry Pharma
First Appointment 10 Jan 2011
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Agastya Biopharm India Limited U24231KA2005PLC036421
Director10 Jan 20112005Active

Directorship timeline

Open interactive timeline →
Agastya Biopharm India Limited
Premium access

Shareholding and investment profile for Madhu Ganghadharan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhu Ganghadharan

Madhu Ganghadharan currently holds 1 directorship: Agastya Biopharm India Limited (Director, since 10 Jan 2011).

Madhu Ganghadharan was first appointed on 10 Jan 2011 as Director at Agastya Biopharm India Limited.

The current boards of Madhu Ganghadharan's companies include Karthikeyan Gopalan (Agastya Biopharm India Limited), Oduvangad Raman Gopalakrishnan (Agastya Biopharm India Limited), Radhakrishnan Sekharan (Agastya Biopharm India Limited), Sidharthan Kochukrishnan Asan (Agastya Biopharm India Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available